RTX's $289 Billion Backlog Is a Promise, Not a Paycheck

One number now carries the bull case for RTX: $289 billion. That's the backlog the aerospace-and-defense giant reported in July — signed orders not yet delivered, totaling roughly three years of its expected sales. Investors throw the figure around like a guarantee of future profits. It isn't. A backlog is a promise of future revenue, not of future profit — and RTX's own recent record shows the distance between the two can be measured in billions.

None of this is semantics. How you read that number decides whether RTX is a compounding income-growth story or a growth stock priced as if the future had already arrived. So let's open the pile and see what's inside.

What "backlog" really means

Backlog is the value of orders customers have placed but a company hasn't yet delivered — the engines, missile interceptors, and aircraft systems booked today for shipment over coming years. At the end of June, RTX's pile reached $289 billion, up 22 percent from a year earlier, equal to about three years of the $95–96 billion in sales it now expects for 2026. That's a degree of revenue visibility almost no other kind of business can offer — and it's been compounding: $218 billion at the end of 2024, $268 billion a year later, $289 billion by mid-2026.

That matters because future sales are the raw material of future earnings and cash. A company holding three years of contracted demand is far less exposed to the next downturn. The real question is what those sales look like when they finally reach the income statement.

What's inside the pile

The $289 billion splits into $170 billion of commercial and $119 billion of defense work. The split matters more than the total, because the two halves convert into money very differently.

The defense half is mostly Raytheon — the missiles and air-defense systems: Patriot, AMRAAM, Tomahawk, Standard Missile. Its backlog alone reached $86 billion, and 48 percent of that is international. This is the geopolitical era's growth line. In the first half of 2026 RTX booked more than $10 billion of international awards, more than double the year-ago level, including over $7 billion from European customers as NATO governments rebuild arsenals. Orders are racing ahead of deliveries — Raytheon alone booked nearly $20 billion in the second quarter, about 2.4 times what it shipped — and company-wide, RTX took in roughly $40 billion of new orders against $24.7 billion of sales. The pile grows even as it gets eaten.

The commercial half is where the accounting gets interesting. It includes Collins Aerospace's aircraft systems and service contracts and, as the largest single piece, Pratt & Whitney's jet engines. Here's the part that breaks the fortress story: RTX sells new commercial engines at a loss on purpose. The profit isn't in the sale; it's in the two or three decades of spare parts, overhauls, and maintenance agreements that follow. A large slice of the commercial backlog is therefore not deferred profit — it's deferred cost, an investment made today in engines that only start returning cash after airlines fly them for years.

Why a bigger backlog isn't a safer one

If you doubt how far the size of a backlog can get from the profit it delivers, look inside Pratt & Whitney itself. In late 2023, RTX discovered that contamination in a manufacturing powder had crept into parts of its GTF engine family, forcing a recall. It took a $3 billion charge that quarter, and early estimates put as many as 350 planes grounded in a single year through 2026. In the end, the mandatory inspections pulled an estimated 600–700 A320neo-family aircraft through repair cycles between 2023 and 2026, and at the actual peak, in early 2026, roughly 650 GTF-powered A320neos — about half the fleet — sat grounded. Airline compensation is still flowing out — roughly $150 million in the second quarter of 2026 alone.

Pause on that. The GTF is simultaneously RTX's biggest commercial backlog line and the source of its most expensive operational failure in years. Every one of those engines was "in the backlog." The backlog measured, faithfully, how much work RTX had promised — and said nothing about what delivering it would cost. Backlog is revenue visibility, not profit insurance.

Where the conversion finally shows up

Here's the constructive part, and it's what the bull case actually rests on. A backlog only matters if it converts — into revenue, then into cash — and RTX's conversion is finally improving.

The clearest evidence is at Pratt & Whitney. Overhaul output rose about 40 percent year over year in the quarter, turnaround times fell roughly 23 percent, and the number of grounded aircraft is down about a quarter from a year ago. Commercial aftermarket sales — the high-margin line that turns engines into annuities — grew 25 percent at Pratt and 10 percent at Collins. At Raytheon, supply chains on mature programs like Patriot have normalized enough that booked orders are finally becoming delivered units.

The result shows up in cash. Free cash flow bottomed at $4.5 billion in 2024 under the weight of the repair program, then nearly doubled to $7.9 billion in 2025. RTX has now raised its 2026 targets — organic sales growth of 8–9 percent, $7.10–7.25 of adjusted earnings per share, and $8.5–8.75 billion of free cash flow. After years in which adjusted earnings looked fine while real cash leaked out, the backlog is finally converting into money.

What it means for income investors

Now apply the funding test. RTX says it has paid a dividend every year since 1936, and the board raised the quarterly payout in April to 73 cents a share, following a similar increase a year earlier. At an annualized $2.92, that's roughly half of trailing earnings — conservative, with room to keep growing.

But notice what you're not getting. Around today's price near $205, RTX yields about 1.4 percent — below the other big defense primes, with Lockheed Martin near 3.1 percent, Northrop 2.2 percent, and General Dynamics 1.7 percent. This is not an income stock. It's a growth compounder that pays a small, rising dividend while the backlog converts. That's a legitimate posture for an income-growth sleeve — the compounding comes from dividend growth working over two decades, not from the starting check. I just wouldn't treat the position as a yield shortcut, and I don't think investors are being paid to chase it as one.

The price of the promise

Which brings up the uncomfortable part of a record backlog: the market can read the press release too. RTX trades near $205 — roughly 29 times the adjusted earnings it's guiding to this year, and around 21 times trailing EBITDA against roughly 13 for Lockheed, 14 for Northrop, and 16 for General Dynamics. A premium over the primes is rational for a company growing organic sales 8–9 percent when peers grow in the mid-single digits. But it means much of the conversion story is already in the price.

The real risks are therefore execution risks. The GTF fleet isn't expected to fully normalize until the end of the decade, and compensation payments keep running. Government customers are sticky but drive hard bargains on contract terms, and airlines can stretch or restructure aircraft programs.

Whenever a company quotes a giant backlog, run it through three questions: What's in it? Does it become cash, or just revenue? And what multiple are you paying for that conversion? By those tests, RTX's $289 billion isn't the story — the conversion of it is. The number is real: three years of inflation-resistant, real-economy demand that is finally funding cash flow and dividend growth. But at this valuation, the backlog is already the market's assumption, not its opportunity. For a long-term income-growth holder, RTX is a quality compounder worth entering on weakness — provided the number is treated as the start of a question, not the answer to one.